Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies
Molecular cancer biomarkers help personalize treatment, predict oncologic outcomes, and identify patients who can benefit from specific targeted therapies. Colorectal cancer (CRC) is the third-most common cancer, with the liver being the most frequent visceral metastatic site. KRAS, NRAS, BRAF V600E...
Main Authors: | Yuliya Kitsel, Timothy Cooke, Vlasios Sotirchos, Constantinos T. Sofocleous |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/6/1679 |
Similar Items
-
Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer
by: David-Dimitris Chlorogiannis, et al.
Published: (2024-04-01) -
The Importance of Optimal Thermal Ablation Margins in Colorectal Liver Metastases: A Systematic Review and Meta-Analysis of 21 Studies
by: David-Dimitris Chlorogiannis, et al.
Published: (2023-12-01) -
Interventional radiological therapies in colorectal hepatic metastases
by: Sai Swarupa R. Vulasala, et al.
Published: (2023-05-01) -
Prognostic circulating proteomic biomarkers in colorectal liver metastases
by: Dongchan Kim, et al.
Published: (2023-01-01) -
Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases
by: Geoffrey Yuet Mun Wong, et al.
Published: (2022-05-01)